Skip to main content

Table 2 Baseline subtype distribution based on NS5B genotyping by treatment arm

From: Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir

HCV subtype (NS5B)

T (N = 8)

TPR (N = 8)

PR (N = 8)

All patients N = 24

 

n (%)

n (%)

n (%)

n (%)

4a

3 (37.5)

4 (50.0)

4 (50.0)

11 (45.8)

4c

1 (12.5)

2 (25.0)

0

3 (12.5)

4d

2 (25.0)

2 (25.0)

0

4 (16.7)

4e

0

0

1 (12.5)

1 (4.2)

4f

0

0

1 (12.5)

1 (4.2)

4h

1 (12.5)

0

0

1 (4.2)

4k

0

0

1 (12.5)

1 (4.2)

4n

1 (12.5)

0

0

1 (4.2)

Genotype unknown

0

0

1 (12.5)

1 (4.2)

  1. N = Number of patients with data; n = Number of patients with that observation.
  2. HCV: Hepatitis C virus; PR: Peginterferon/ribavirin arm; T: Telaprevir monotherapy arm; T/PR: Telaprevir plus peginterferon/ribavirin arm.
Back to article page

Virology Journal

ISSN: 1743-422X